| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |